Grupa Azoty (ATT) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
27 Oct, 2026Executive summary
2025 EBITDA improved to PLN 323m from a PLN 330m loss in 2024; excluding Grupa Azoty Polyolefins (GAP), EBITDA was PLN 350m.
Revenue was PLN 13.1bn, versus PLN 13.0bn in 2024; Agro was the main earnings driver, while Chemicals and Plastics remained loss-making.
An agreement with Orlen and a creditor arrangement for GAP are expected to reduce debt and financial exposure, enabling renewed focus on core businesses.
Financial highlights
Revenue reached PLN 13.1bn in 2025, compared with PLN 13.0bn in 2024 and PLN 13.5bn in 2023.
Reported EBITDA was PLN 323m, versus a PLN 330m loss in 2024; EBITDA excluding GAP was PLN 350m, versus a PLN 112m loss in 2024.
Reported EBIT was a PLN 5.260bn loss and net income a PLN 5.145bn loss; excluding GAP, EBIT was a PLN 639m loss and net income a PLN 776m loss.
EBITDA improved by PLN 653m YoY, supported by Agro (+PLN 386m), Plastics (+PLN 223m), Chemicals (+PLN 117m), Energy (+PLN 100m) and Other (+PLN 27m).
Outlook and guidance
The Nowe Horyzonty program targets operational and organizational simplification, production optimization, asset portfolio review and sales growth through digital tools and data analytics.
The planned sale of Polimery Police to Orlen is positioned as a step to lower debt and refocus on core business activities.
Agro priorities include specialist and foliar product expansion, production efficiency investments, a farmer sales platform and the GARDEN line for individual customers.
COMPO EXPERT Polska plans to expand biostimulants and microbiological products, strengthen distributor-supported technical advice and introduce fertilizer decision tools.
Latest events from Grupa Azoty
- Sales grew, but losses, market headwinds and financing uncertainty persisted.ATT
Q1 2025 - Q3 rebounded on a one-off settlement, but losses and financing risks persist.ATT
Q3 2025 - EBITDA rebounded to PLN 316.5m, but funding risks and Polyolefins’ conditional sale remain.ATT
Q1 2026 - Q2 EBITDA rebounded, but financing and restructuring risks persist.ATT
Q2 2026 - Q2 EBITDA rebounded to PLN 294m as Chemicals and Agro strengthened.ATT
Q2 2026 - EBITDA surged to PLN 316.5 million as profitability improved and restructuring advanced.ATT
Q1 2026 - EBITDA rebounded on a one-off gain, with revenue up and major restructuring underway.ATT
Q3 2025 - Revenue up 12.4% YoY; Agro leads growth, but net loss persists amid restructuring.ATT
Q1 2025 - EBITDA improved and net loss narrowed, supported by cost cuts and CapEx reduction.ATT
Q4 2024